Urinary bladder dysfunction, which is one of the most common diabetic complications, is associated with alteration of bladder smooth muscle contraction. However, details regarding the responses under high-glucose (HG) conditions in diabetes are poorly understood. The objective of this study was to identify a relationship between extracellular glucose level and bladder smooth muscle contraction in diabetes. Bladder smooth muscle tissues were isolated from spontaneously type II diabetic (ob/ob mouse; 16 -20 weeks of age, male) and age-matched control (C57BL mouse) mice. Carbachol (CCh) induced timeand dose-dependent contractions in ob/ob and C57BL mice; however, maximal responses differed significantly (14.34 Ϯ 0.32 and 12.69 Ϯ 0.22 mN/mm 2 after 30 M CCh treatment, respectively; n ϭ 5-8). Pretreatment of bladders under HG conditions (22.2 mM glucose; concentration is twice that of normal glucose for 30 min) led to enhancement of CCh-induced contraction solely in diabetic mice (15.9 Ϯ 0.26 mN/mm 2 ; n ϭ 5). Basal extracellular glucose-dependent enhancement of bladder contraction in diabetes was documented initially in this study. The correlation between intracellular calcium concentration and contraction was enhanced only in the ob/ob mouse. This enhancement of contraction and total protein kinase C (PKC) activity were inhibited by pretreatment with not only a PKC inhibitor (rottlerin) but also with a rho kinase inhibitor, fasudil [1-(5-isoquinolinesulfonyl)homopiperazine HCl]. These reagents also suppressed the differences between ob/ob and C57BL mouse bladder contractions under HG conditions. The data indicated that glucose-dependent enhancement of contraction in diabetic bladder is involved in the activation of the rho kinase and calcium-independent PKC pathways. This dysfunction may contribute to bladder complications such as detrusor overactivity and reduced bladder capacity in diabetes.It is estimated that diabetes mellitus currently affects more than 150 million people worldwide (Engelgau et al., 2003); moreover, this number is expected to increase to approximately 300 million by 2025(Zimmet et al., 2001Permutt et al., 2005). Diabetic patients display numerous diabetic complications (e.g., retinopathy, nephropathy, and neurosis) dependent on the extent of the damage caused by disease progression; furthermore, these individuals are threatened by complications, leading to cardiovascular damage (Gillies and Su, 1993;Stockand and Sansom, 1997). Diabetic bladder dysfunction is among the most common and costly consequences of diabetes; dysfunctions include decreased bladder sensation, increased bladder capacity, and impaired bladder emptying with resultant increased postvoid residual urine. As a result, urinary incontinence in the diabetic patient has been most commonly attributed to overflow incontinence as a sign of voiding problems. Estimates of the prevalence of dysfunction range from 25 to 85% (Starer and Libow, 1990;Ueda et al., 1997;Brown et al., 2005). Although this condition is not life-threateni...